NCT01543802 Study of Preoperative Therapy With Pazopanib (Votrient®) to Treat High-risk Soft Tissue Sarcoma Status TERMINATED Phase PHASE2
NCT01542047 A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies Status TERMINATED Phase PHASE1
NCT01541852 Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen. Status COMPLETED Phase PHASE2
NCT01541475 Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE4
NCT01540734 Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Status COMPLETED Phase PHASE1
NCT01540721 Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend Status COMPLETED Phase PHASE1
NCT01540708 A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol Status COMPLETED Phase PHASE1
NCT01536678 Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers Status COMPLETED Phase PHASE4
NCT01536574 Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528 Status COMPLETED Phase PHASE3
NCT01536561 Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT01536418 An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease Status TERMINATED Phase PHASE3
NCT01536379 A Study of Belimumab in the Prevention of Kidney Transplant Rejection Status COMPLETED Phase PHASE2
NCT01536067 Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia Status TERMINATED Phase PHASE2
NCT01534897 Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 Status COMPLETED Phase NA
NCT01528865 Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma Status WITHDRAWN Phase PHASE1/PHASE2